Keywords: ph, iia, results, dyax, dx-890, promising, preliminary

Ph IIa results for Dyax' DX-890

Article | 01 March 2004

Print This

Promising preliminary findings have been released by Dyax Corp and Debiopharm AS from a Phase IIa dose-escalating trial evaluating DX-890 ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in